Skip to main content
. Author manuscript; available in PMC: 2011 May 4.
Published in final edited form as: Mol Cancer Res. 2010 May 4;8(5):729–738. doi: 10.1158/1541-7786.MCR-10-0022

Figure 3.

Figure 3

The proteasome was inhibited equally in all RCC tested. (a) Cells were treated overnight with 1, 10 or 20 nM Bortezomib and then assayed with the Proteo-glo assay (Promega). (b) Cells were treated overnight with 20 nM Bortezomib; cell lysates were used for western blotting for ubiquitinated proteins.